Modulation of epitope‐specific anti‐hepatitis C virus E2 (anti‐HCV/E2) antibodies by anti‐viral treatment.

MLA

Nicasio Mancini, et al. “Modulation of Epitope‐specific Anti‐hepatitis C Virus E2 (Anti‐HCV/E2) Antibodies by Anti‐viral Treatment.” Journal of Medical Virology, vol. 78, no. 10, Oct. 2006, pp. 1304–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=22432467&authtype=sso&custid=ns315887.

APA

Nicasio Mancini, Silvia Carletti, Mario Perotti, Luisa Romanò, Rosellina Di Stefano Craxì, Antonio Craxì, Alessandro R. Zanetti, Massimo Clementi, & Roberto Burioni. (2006). Modulation of epitope‐specific anti‐hepatitis C virus E2 (anti‐HCV/E2) antibodies by anti‐viral treatment. Journal of Medical Virology, 78(10), 1304–1311.

Chicago

Nicasio Mancini, Silvia Carletti, Mario Perotti, Luisa Romanò, Rosellina Di Stefano Craxì, Antonio Craxì, Alessandro R. Zanetti, Massimo Clementi, and Roberto Burioni. 2006. “Modulation of Epitope‐specific Anti‐hepatitis C Virus E2 (Anti‐HCV/E2) Antibodies by Anti‐viral Treatment.” Journal of Medical Virology 78 (10): 1304–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=22432467&authtype=sso&custid=ns315887.